However, whether the upregulation of AQP7 in muscle promotes the pathophysiological development of obese T2DM or is merely a response to the reduced insulin-mediated lipid oxidation inhibition in insulin resistance remains to be further studied [111]. This evidence concerns the gene AQP7 and Insulin resistance.